Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Summit Therapeutics Inc. (SMMT)

14.27 +0.02 (+0.11%)
As of 11:34:06 AM EDT. Market Open.
Trade SMMT on Coinbase
Chart Range Bar
Loading chart for SMMT
  • Previous Close 14.25
  • Open 14.25
  • Bid 13.33 x 200
  • Ask 15.41 x 200
  • Day's Range 14.17 - 14.55
  • 52 Week Range 12.55 - 30.98
  • Volume 1,291,064
  • Avg. Volume 5,170,425
  • Market Cap (intraday) 11.072B
  • Beta (5Y Monthly) -1.31
  • PE Ratio (TTM) --
  • EPS (TTM) -1.59
  • Earnings Date (est.) Apr 30, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 28.18

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.

www.smmttx.com

265

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SMMT
18.44%
S&P 500 (^GSPC)
8.42%

1-Year Return

SMMT
31.81%
S&P 500 (^GSPC)
21.82%

3-Year Return

SMMT
438.30%
S&P 500 (^GSPC)
70.68%

5-Year Return

SMMT
121.51%
S&P 500 (^GSPC)
73.95%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -139.49M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-400M
-300M
-200M
-100M
0

Analyst Insights

View More

Analyst Price Targets

9.75
28.18 Average
14.27 Current
43.96 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 5/22/2026
Analyst Bernstein
Rating Action Initiated
Rating Underperform
Price Action Announces
Price Target 7.7

Statistics

View More

Valuation Measures

Annual
As of 6/23/2026
  • Market Cap

    11.06B

  • Enterprise Value

    10.48B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    20.26

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -148.15%

  • Return on Equity (ttm)

    -270.95%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -1.21B

  • Diluted EPS (ttm)

    -1.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    598.73M

  • Total Debt/Equity (mrq)

    3.67%

  • Levered Free Cash Flow (ttm)

    69.88M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

14.27 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 06/15/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 06/05/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 09/12/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 03/28/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: